Surginex is a biotechnology startup founded in 2020 and has recently received a significant KRW8.50B Venture Round investment on 27 March 2024. The investment was contributed by a group of prominent investors including Partners Investment, Posco Capital, LSK Investment, Hana Ventures, Laguna Investment, and Kiwoom Investment. This substantial financial backing signifies growing confidence in Surginex's innovative solutions within the biotechnology sector. The company's progress and the caliber of its investors bode well for its potential for future growth and impact within the industry.
Surginex
Founded 2020
Series B
Total: $12.50B
Biotechnology, Medical Devices
General Information
Company Name
Surginex
Founded Year
2020
Industries
Biotechnology, Medical Devices
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with Surginex. To contact Surginex, visit surginex.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About Surginex
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | KRW8.50B | 6 |
|
27 Mar 2024 |
| Series A | KRW4.00B | 2 |
|
11 Nov 2021 |
FAQ About Surginex
Surginex was founded in 2020.
Surginex operates in Biotechnology and Medical Devices.
Surginex has completed 2 funding rounds, raising a total of $12.50B. The latest funding stage is Series B.
We're actively collecting intelligence on Surginex.
Source: BounceWatch company record for Surginex, https://bouncewatch.com/company/surginex, updated 1 August 2024. When citing, please name BounceWatch and link this page.
